| |
| |
|
| Insider
Information: |
Fischer Laurent |
| Relationship: |
CEO, President and Dir... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
698,891 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,727,611 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
698,891 |
|
|
| Total
Value |
$6,727,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
6
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-6.0
|
0.0
|
| Percentage
Gain/Loss : |
 -58.2%
|
 46.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tobira Therapeutics Inc |
TBRA |
|
|
0 |
|
0 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
|
|
0 |
|
0 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
Director |
2019-09-17 |
6,750 |
2019-09-06 |
0 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
CEO, President and Dir... |
2023-03-15 |
692,141 |
2020-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2023-03-15 |
4 |
S |
$0.78 |
$32,232 |
D/D |
(41,239) |
692,141 |
0 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2022-09-19 |
4 |
S |
$1.07 |
$43,941 |
D/D |
(41,082) |
727,380 |
0 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2022-04-20 |
4 |
B |
$1.11 |
$27,800 |
D/D |
25,000 |
762,462 |
2.81 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2021-12-09 |
4 |
B |
$1.85 |
$26,498 |
D/D |
14,323 |
737,462 |
2.81 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2021-12-08 |
4 |
B |
$1.79 |
$19,112 |
D/D |
10,677 |
723,139 |
2.81 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO, President and Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
680,000 |
706,292 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO and Director |
• • – |
2021-03-24 |
4 |
B |
$9.88 |
$98,780 |
D/D |
10,000 |
26,292 |
2.81 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO and Director |
• • – |
2021-01-15 |
4 |
B |
$11.53 |
$99,191 |
D/D |
8,600 |
16,292 |
2.81 |
% |
|
| ADVM |
Adverum Biotechnologies, ... |
CEO and Director |
• • – |
2020-08-17 |
4 |
B |
$13.00 |
$99,996 |
D/D |
7,692 |
7,692 |
2.81 |
% |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Director |
– • – |
2019-09-17 |
4 |
B |
$9.37 |
$15,435 |
D/D |
1,648 |
6,750 |
2.39 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Director |
– • – |
2019-09-16 |
4 |
B |
$9.47 |
$4,280 |
D/D |
452 |
5,102 |
2.31 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Director |
– • – |
2019-09-10 |
4 |
B |
$10.29 |
$9,881 |
D/D |
960 |
4,650 |
2.39 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Director |
– • – |
2019-09-09 |
4 |
B |
$10.54 |
$20,992 |
D/D |
1,970 |
3,690 |
2.39 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Director |
– • – |
2019-09-06 |
4 |
B |
$10.71 |
$18,429 |
D/D |
1,720 |
1,720 |
2.39 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
